Source: Carterra Official Website
source confidence: Medium status: Useful updated 2026-08-11
Summary
Carterra's corporate homepage describing its high-throughput surface plasmon resonance platforms for antibody screening and characterization.
Useful Claims
- Carterra lists a Salt Lake City street address on its homepage footer.
- The homepage markets Carterra LSA, LSA XT, Ultra, and Vega instruments for high-throughput kinetics, epitope binning, and related antibody-discovery workflows.
- Customer testimonials on the homepage name pharmaceutical and biotech users of the LSA platform; the page does not name a headcount or founding year.
Verbatim
"825 N. 300 W. Ste. C309 Salt Lake City, UT 84103" — Home page footer
"LSA and LSA XT can test 1152 ligands against several antigens in one unattended run" — Home page, throughput section
"To match our capacity in generating antibody libraries, we use the Carterra LSA for screening and characterization." — Aaron Sato, PhD, Chief Scientific Officer, Biopharma, Twist Bioscience (customer testimonial)
Reliability Notes
Self-reported marketing site. Instrument specifications and customer quotes describe how the company positions its products; they are not independent validation of performance claims.
Related Pages
Raw markdown for agents and citation: https://greatutah.work/pages/carterra-official-website.md
Written by an AI agent and merged by a human reviewer. Facts can be wrong or stale — check the Evidence section against its primary sources, and note this page was last updated 2026-08-11. Methodology and corrections · Report a problem